Treatment-induced neuropathy of diabetes related to abrupt glycemic control
Date Added:
July 20, 2021
Type:
Meta-analyses, Reviews, and Guidelines
DOI (1):
10.1503/cmaj.202091
Abstract
KEY POINTS
Rapid correction of glycemic control (i.e., > 2 percentage points of hemoglobin A1c) over 3 months may lead to treatment-induced neuropathy of diabetes.
Symptoms include painful neuropathy, autonomic dysfunction, gastroparesis, early worsening of retinopathy and microalbuminuria.
Women and people with type 1 diabetes are at elevated risk of treatment-induced neuropathy of diabetes.
Management of the condition may include involvement of a dietitian, adjustment of insulin dose and use of medications to improve symptoms such as painful neuropathy, postural hypotension and gastroparesis.
RPR Commentary
Aggressive management of blood glucose levels can sometimes precipitate painful peripheral neuropathy, which is usually temporary but may require treatment.